ADENOVIRUS-VEKTOREN
European patent · EP2459716 · In force
Register entry
- Publication number
- EP2459716
- Application number
- EP10805122
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 30, 2010
- Published
- Jun 6, 2012
- Granted
- Aug 17, 2016
- Protection ends at the latest
- Jul 29, 2030
- Next annual fee due
- Jul 31, 2026
- IPC classes
- C12N 15/00 (2006.01)A61K 31/70 (2006.01)
- Priority
- US 230617 P 31.07.2009
- PCT application
- PCT/US2010/043951 30.07.2010
- PCT publication
- WO2011/014794 03.02.2011
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2025
Change
Published in Swissreg on 01.08.2025
- Aug 1, 2024
Change
Published in Swissreg on 01.08.2024
- Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
- Aug 1, 2022
Change
Published in Swissreg on 01.08.2022
- Mar 14, 2022
Agent removed
- Representative
- VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern (removed)
Published in Swissreg on 14.03.2022
- Mar 14, 2022
Address changed
- Owner
- Paxvax, Inc., 3985A Sorrento Valley Boulevard, San Diego, California 92121, USA → EMERGENT TRAVEL HEALTH INC., 555 Twin Dolphin Drive, Suite 360, Redwood City, California 94065, USA
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in Swissreg on 14.03.2022
- Nov 16, 2016
Agent entered
- Representative
- VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern
Published in Swissreg on 16.11.2016
- Aug 17, 2016
Granted
Published in Swissreg on 17.08.2016
Parties
Inventor
San Diego California 92121, US
San Diego California 92121, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.